The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL).

NCT02924753 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER_GOV

Sponsor class

Conditions

B-cell Acute Lymphoblastic Leukemia

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: CART-19 cells

Sponsor

Henan Cancer Hospital

Collaborators

[object Object]